Carl Lovely

University Of Texas Arlington

$2,265,833

Attributed

$2,265,833

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $528.6K · FY2005–25

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,265,833 · 4

By mechanism

R15$1,203,888 · 3

R01$1,061,945 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Arlington

Same institution · by research overlap

Justyn Jaworski$1,017,171
Jian Yang$5,791,905
Bradley S Pierce$1,169,867
Junha Jeon$1,322,959

Others in their field

Top investigators on “Imidazole”

Doug Livingston · Compound Focus, Inc.$12,277,761
Kenneth D. Karlin · Johns Hopkins University$9,864,174
Alexandros Makriyannis · University Of Connecticut Storrs$9,810,947
Sharon L Reed · University Of California San Diego$9,464,695
Philip Lograsso · Scripps Research Institute, The$7,700,546
Valerian E Kagan · Wistar Institute$6,184,366

Research focus

ImidazoleExhibitsBiologicalReactionAlkaloidsAnti-Bacterial AgentsOroidinPoriferaInvestigationComplexPropertyDiels Alder ReactionNitrogenPalau&AposAgelasPositioning AttributeMemberAdductMethodologyChemical SynthesisAmineMarinesChemistryBiological Factors